Time-dependent change in relapse sites of renal cell carcinoma after curative surgery

Autor: Takeharu Yamanaka, Kazuhiro Namura, Sachi Fukui, Masato Yasui, Yoko Saito, Kazuki Kobayashi, Koichi Abe, Daiki Ueno, Kazuo Kitami, Noboru Nakaigawa, Taku Mitome, Akitoshi Takizawa, Junichi Ohta, Go Noguchi, Sohgo Tsutsumi, Masahiro Yao, Tomoyuki Tatenuma, Teiichiro Ueki, Keiichi Kondo, Susumu Umemoto, Takashi Tokita, Takeshi Watanabe, Shinnosuke Kuroda, Takeshi Kishida, Masataka Taguri, Hitomi Kanno

Publikováno v: Clinical & Experimental Metastasis. 35:69-75

We investigated time-dependent changes in the relapse features of renal cell carcinoma (RCC) after curative surgery. Between 1985 and 2015, 1398 patients with RCC (1226 clear cell RCC, 89 papillary RCC, and 53 chromophobe RCC) underwent curative surg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5792eb1b19aa1610be45dfc1d7f0e76a
https://doi.org/10.1007/s10585-018-9883-0

Androgen deprivation therapy prevents bladder cancer recurrence

Autor: Masatoshi Moriyama, Maho Sato, T. Murai, Satoshi Morita, Kazuo Kitami, Yoshinori Hara, Teiichiro Ueki, Yasuhide Miyoshi, Kiyoshi Fujinami, Futoshi Tsuchiya, Ichiro Ikeda, Takeshi Kishida, Hiroshi Miyamoto, Kimio Chiba, Kotaro Hirai, Hiroji Uemura, Masataka Taguri, Kotaro Suzuki, Kazumi Noguchi, Koichi Udagawa, Koji Izumi, Kazuki Kobayashi

Publikováno v: Oncotarget
Scopus-Elsevier

// Koji Izumi 1 , Masataka Taguri 2 , Hiroshi Miyamoto 3 , Yoshinori Hara 4 , Takeshi Kishida 5 , Kimio Chiba 6 , Tetsuo Murai 7 , Kotaro Hirai 8 , Kotaro Suzuki 9 , Kiyoshi Fujinami 10 , Teiichiro Ueki 11 , Koichi Udagawa 12 , Kazuo Kitami 13 , Masa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58114f0e0481c1bf1d4f41c8d27348d9
https://pubmed.ncbi.nlm.nih.gov/25557268

[Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia]

Autor: Takehiko, Ogawa, Hiroji, Uemura, Futoshi, Sano, Kouji, Hoshino, Kaoru, Kita, Narihiko, Hayashi, Masayo, Kagota, Takayuki, Murakami, Kazuhide, Makiyama, Yasuhide, Miyoshii, Noboru, Nakaigawa, Masahiro, Yao, Hidetoshi, Shimura, Akihiko, Furuhata, Naoya, Fujikawa, Koichi, Shioi, Teiichiro, Ueki, Yoshinori, Hara, Kiyoshi, Saitou, Satoshi, Kawakami, Yoshiaki, Satomi, Yusuke, Hattori, Junichi, Teranishi, Keiichi, Kondo, Takeshi, Kishida, Kazuo, Saito, Kazumi, Noguchi, Hiroshi, Fuji, Toyoaki, Yamaguchi, Yuzo, Kinoshita, Sakae, Nomura, Minoru, Yoshida, Naoki, Sakai, Hideyuki, Terao, Tatsuya, Matsumoto, Susumu, Umemoto, Yoshiharu, Ogo, Kazuki, Kobayashi, Sumio, Noguchi, Tomoyuki, Asakura, Teruo, Kohdaira, Kozue, Iguchi, Koji, Izumi, Masami, Hirano, Hitomi, Kanno, Toshihiro, Takahashi, Fumihiko, Nukui, Yasuhiro, Mokuo, Kentaro, Muraoka, Yutaka, Osada, Makoto, Funahashi, Kazuo, Kitami, Shimpei, Sugiura, Junichi, Ohta, Takeshi, Miura, Yoshio, Ishibashi, Mitsunobu, Masuda, Atsushi, Komiya, Yutaka, Suwa, Takafumi, Hashiba, Kunihisa, Mitaka, Masataka, Kobayashi, Kimito, Ohsaka, Takano, Futoshi, Tetsuzo, Tsuchiya, Akira, Iwasaki, Yuzo, Yamashita, Junichi, Matsuzaki, Yoshinobu, Kubota

Publikováno v: Hinyokika kiyo. Acta urologica Japonica. 54(12)

Silodosin (URIEF), a new so-called 3rd generation alpha-1 blocker, is widely expected to be effective and useful for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), due to its high specificity to alpha-1A recep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8dc3ca574b845b94c0330461d8515b9f
https://pubmed.ncbi.nlm.nih.gov/19174997

Androgen deprivation therapy to prevent bladder cancer recurrence

Autor: Kotaro Suzuki, Yoshinori Hara, Futoshi Tsuchiya, Satoshi Morita, Takeshi Kishida, Yasuhide Miyoshi, Tetsuo Murai, Kazuki Kobayashi, Masatoshi Moriyama, Hiroshi Miyamoto, Hiroji Uemura, Kimio Chiba, Kotaro Hirai, Koji Izumi, Kazuo Kitami, Teiichiro Ueki, Masataka Taguri, Ichiro Ikeda, Koichi Udagawa, Kiyoshi Fujinami

Publikováno v: Journal of Clinical Oncology. 33:329-329

329 Background: Accumulating preclinical evidence indicates the involvement of androgen receptor signals in bladder cancer (BC) development and further suggests androgen deprivation therapy (ADT) as a new therapeutic option for BC. However, the clini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::212f836417b61f471595d5c7916191e9
https://doi.org/10.1200/jco.2015.33.7_suppl.329

[Pheochromocytoma associated with neurofibromatosis 1: a report of two cases]

Autor: Futoshi, Sano, Naoya, Fujikawa, Kotaro, Hirai, Teiichiro, Ueki, Kazuo, Kitami

Publikováno v: Hinyokika kiyo. Acta urologica Japonica. 51(12)

Pheochromocytomas may occur as either sporadic or familial tumors. Clinical features of pheochromocytomas in neurofibromatosis 1 (NF1) patients are similar to those in patients with sporadic pheochromocytomas, unlike pheochromocytomas associated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d373f06c3fb573aa2250d188b0aa8f13
https://pubmed.ncbi.nlm.nih.gov/16440725